Bourne Lent Asset Management’s Amgen AMGN Stock Holding History

Bourne Lent Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.43M	Hold	9,740	–	–	1.26%	20
2025 Q4	$3.19M	Sell	9,740 -200	-2%	-$63.4K	1.06%	17
2025 Q3	$2.81M	Sell	9,940 -400	-4%	-$116K	1%	20
2025 Q2	$2.89M	Buy	10,340 +720	+7%	+$204K	1.12%	18
2025 Q1	$3M	Sell	9,620 -200	-2%	-$59.1K	1.29%	17
2024 Q4	$2.56M	Buy	9,820 +50	+0.5%	+$14.8K	0.98%	20
2024 Q3	$3.15M	Buy	9,770 +25	+0.3%	+$8.18K	1.19%	16
2024 Q2	$3.04M	Sell	9,745 -75	-0.8%	-$22K	1.17%	16
2024 Q1	$2.79M	Buy	9,820 +100	+1%	+$29.3K	1.13%	16
2023 Q4	$2.8M	Buy	9,720 +340	+4%	+$92.6K	1.14%	17
2023 Q3	$2.52M	Hold	9,380	–	–	1.11%	16
2023 Q2	$2.08M	Sell	9,380 -350	-4%	-$81.2K	0.73%	22
2023 Q1	$2.35M	Hold	9,730	–	–	0.89%	19
2022 Q4	$2.56M	Sell	9,730 -272	-3%	-$72.9K	1.1%	19
2022 Q3	$2.25M	Hold	10,002	–	–	0.98%	21
2022 Q2	$2.43M	Hold	10,002	–	–	0.97%	21
2022 Q1	$2.42M	Buy	10,002 +400	+4%	+$91.9K	0.76%	21
2021 Q4	$2.16M	Buy	9,602 +4,465	+87%	+$942K	0.58%	25
2021 Q3	$1.09M	Hold	5,137	–	–	0.31%	32
2021 Q2	$1.25M	Hold	5,137	–	–	0.35%	32
2021 Q1	$1.28M	Hold	5,137	–	–	0.41%	31
2020 Q4	$1.18M	Sell	5,137 -200	-4%	-$46.1K	0.39%	31
2020 Q3	$1.36M	Hold	5,337	–	–	0.52%	26
2020 Q2	$1.26M	Hold	5,337	–	–	0.54%	25
2020 Q1	$1.08M	Buy	5,337 +150	+3%	+$32.8K	0.58%	25
2019 Q4	$1.25M	Buy	5,187 +300	+6%	+$66.1K	0.59%	23
2019 Q3	$946K	Hold	4,887	–	–	0.45%	25
2019 Q2	$901K	Hold	4,887	–	–	0.43%	25
2019 Q1	$928K	Hold	4,887	–	–	0.46%	25
2018 Q4	$951K	Hold	4,887	–	–	0.56%	25
2018 Q3	$1.01M	Hold	4,887	–	–	0.48%	25
2018 Q2	$902K	Hold	4,887	–	–	0.48%	25
2018 Q1	$833K	Sell	4,887 -440	-8%	-$80.8K	0.45%	26
2017 Q4	$926K	Hold	5,327	–	–	0.5%	27
2017 Q3	$993K	Sell	5,327 -100	-2%	-$17.7K	0.51%	27
2017 Q2	$935K	Buy	5,427 +250	+5%	+$40.7K	0.51%	27
2017 Q1	$849K	Hold	5,177	–	–	0.46%	30
2016 Q4	$757K	Buy	5,177 +1,500	+41%	+$226K	0.45%	29
2016 Q3	$613K	Hold	3,677	–	–	0.45%	30
2016 Q2	$559K	Buy	3,677 +172	+5%	+$26.7K	0.44%	31
2016 Q1	$526K	Hold	3,505	–	–	0.42%	32
2015 Q4	$569K	Hold	3,505	–	–	0.43%	31
2015 Q3	$485K	Hold	3,505	–	–	0.4%	30
2015 Q2	$538K	Sell	3,505 -250	-7%	-$40K	0.42%	31
2015 Q1	$600K	Buy	+3,755	New	+$591K	0.45%	33

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bourne Lent Asset Management's AMGN Position: Q1 2026 in Review

Bourne Lent Asset Management held its Amgen (AMGN) position steady in Q1 2026 at 9,740 shares worth $3.43M. The position accounts for 1.26% of the portfolio, ranked #20.

Bourne Lent Asset Management first reported a position in AMGN in Q1 2015 and has held it in 45 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Bourne Lent Asset Management held 9,740 shares of Amgen worth $3.43M as of Q1 2026.
Bourne Lent Asset Management left its Amgen share count unchanged in Q1 2026.
Amgen made up 1.26% of Bourne Lent Asset Management's portfolio in Q1 2026, its #20 holding.
Bourne Lent Asset Management first reported a position in Amgen in Q1 2015 and has held it in 45 quarters since.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bourne Lent Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.